Skip to content
All cases
Neema S.Neema S., photo 2Neema S., photo 3
1/5
  1. Request received25.07.2026
  2. Checked & Confirmed28.08.2026
  3. FundraisingDone in 26 days
  4. Treatment provided18.07.2026
  5. Invoice paid
  6. Case closed

Why is treatment done earlier than admission?

Sometimes, when a case is urgent and vital, hospitals may proceed with delivering medical care right away to save a life, even before the finalization of admission procedures. Usually, when this happens, hospitals put the bill on our credit until the funds are transferred to their accounts.

That's why the chronology can sometimes be in disorder.

InvoiceMedical Report

Download Helpster App to get an access to full reports and documents

Download on the App StoreGet it on Google Play

Neema S., 9

In treatment

Kenya

Diagnosis

Blood

Required Amount

$180

Thank you for saving this life!

Raised in 26 days

$180/$180

100%

Bulondo Health CentreBulondo-Namwacha - full address is neededHospital contacts
Background

Neema is a determined 9-year-old Grade Five pupil and the eldest of four children. Her mother died while delivering the youngest child, leaving her father as the sole provider. He works as a cane cutter, earning approximately USD 200 monthly. The family lives in a small mud house without electricity and walks over 30 minutes to obtain water. Neema dreams of joining the Kenya Defence Forces. Neema, who has sickle cell disease, became seriously ill four days before admission, developing high fever, chills, headache and repeated vomiting. Her condition progressively deteriorated, with profound weakness, severe pallor, dizziness, poor appetite and increasing lethargy. She became too weak to play or walk even short distances without exhaustion and breathlessness, spending most of her time lying down. Her father described this episode as considerably worse than her previous sickle cell crises. His limited income had made it difficult to consistently obtain Neema’s routine sickle cell medicines or seek care promptly. With her condition becoming increasingly alarming and few financial options available, he brought her to hospital after learning about Helpster Charity.

Medical history

Neema, a 9-year-old child, was admitted with severe anaemia secondary to severe Plasmodium falciparum malaria and underlying sickle cell disease. Initial management included prompt assessment, intravenous artesunate to treat severe malaria, blood transfusion to correct the severe anaemia, intravenous fluids administered cautiously, oxygen therapy as needed, antipyretics for fever, and close monitoring of vital signs, haemoglobin level, blood glucose, and signs of complications. During hospitalization, supportive care was continued with adequate hydration, nutritional support, pain management for sickle cell disease if required, and treatment of any associated infections. Regular laboratory investigations were performed to monitor haemoglobin levels, malaria parasite clearance, and overall clinical progress. The child was observed closely for transfusion reactions, recurrent fever, and other complications related to severe malaria and sickle cell disease. Following treatment, Neema's haemoglobin level improved, fever subsided, and repeat blood smears showed clearance of malaria parasites. Her general condition stabilised, with improved appetite, energy, and vital signs. She was discharged in good condition with antimalarial follow-up, folic acid supplementation, counselling on sickle cell disease management, and advice for regular clinic reviews and prompt medical attention if symptoms recurred.

Prognosis

Neema, a known sickle cell patient, presented with severe malaria, severe anaemia and sickle cell crisis, a potentially life-threatening combination. Malaria can accelerate red-cell destruction and worsen anaemia, while sickling may further compromise oxygen delivery to tissues. Urgent antimalarial therapy, management of the crisis, correction of severe anaemia including transfusion when indicated, hydration and close monitoring are essential. With timely treatment and good clinical response, her prognosis is cautiously favourable, although regular sickle cell follow-up remains necessary.